SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-002208
Filing Date
2012-05-08
Accepted
2012-05-08 13:47:35
Documents
13
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 361535
2 CERTIFICATION sbfm_ex311.htm EX-31.1 14837
3 CERTIFICATION sbfm_ex312.htm EX-31.2 14674
4 CERTIFICATION sbfm_ex32.htm EX-32 8210
5 img001.jpg GRAPHIC 20005
6 img002.jpg GRAPHIC 27693
7 img003.jpg GRAPHIC 16738
  Complete submission text file 0001354488-12-002208.txt   1101983

Data Files

Seq Description Document Type Size
8 sbfm-20120331.xml EX-101.INS 48950
9 sbfm-20120331.xsd EX-101.SCH 6993
10 sbfm-20120331_lab.xml EX-101.LAB 60430
11 sbfm-20120331_pre.xml EX-101.PRE 43263
12 sbfm-20120331_def.xml EX-101.DEF 4721
13 sbfm-20120331_cal.xml EX-101.CAL 18404
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 12820733
SIC: 8742 Services-Management Consulting Services